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Merlin/NF2 Signaling
Raj R. Malinda, Katrine Zeeberg, Patricia C. Sharku, Mette Q. Ludwig, Lotte B. Pedersen,
Søren T. Christensen and Stine F. Pedersen*
Section for Cell Biology and Physiology, Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen,
Denmark
Pancreatic ductal adenocarcinoma (PDAC) is a major cause of cancer-related death,
with a 5-year survival of <10% and severely limited treatment options. PDAC hallmarks
include profound metabolic acid production and aggressive local proliferation and
invasiveness. This phenotype is supported by upregulated net acid extrusion and
epithelial-to-mesenchymal transition (EMT), the latter typically induced by aberrant
transforming growth factor-β (TGFβ) signaling. It is, however, unknown whether
TGFβ-induced EMT and upregulation of acid extrusion are causally related. Here, we
show that mRNA and protein expression of the net acid extruding transporters Na+/H+
exchanger 1 (NHE1, SLC9A1) and Na+, HCO−3 cotransporter 1 (NBCn1, SLC4A7)
are increased in a panel of human PDAC cell lines compared to immortalized human
pancreatic ductal epithelial (HPDE) cells. Treatment of Panc-1 cells (which express
SMAD4, required for canonical TGFβ signaling) with TGFβ-1 for 48 h elicited classical
EMT with down- and upregulation of epithelial and mesenchymal markers, respectively,
in a manner inhibited by SMAD4 knockdown. Accordingly, less pronounced EMT was
induced in BxPC-3 cells, which do not express SMAD4. TGFβ-1 treatment elicited a
SMAD4-dependent increase in NHE1 expression, and a smaller, SMAD4-independent
increase in NBCn1 in Panc-1 cells. Consistent with this, TGFβ-1 treatment led to
elevated intracellular pH and increased net acid extrusion capacity in Panc-1 cells,
but not in BxPC-3 cells, in an NHE1-dependent manner. Proliferation was increased
in Panc-1 cells and decreased in BxPC-3 cells, upon TGFβ-1 treatment, and this, as
well as EMT per se, was unaffected by NHE1- or NBCn1 inhibition. TGFβ-1-induced
EMT was associated with a 4-fold increase in Panc-1 cell invasiveness, which further
increased∼10-fold upon knockdown of the tumor suppressor Merlin (Neurofibromatosis
type 2). Knockdown of NHE1 or NBCn1 abolished Merlin-induced invasiveness, but
not that induced by TGFβ-1 alone. In conclusion, NHE1 and NBCn1 expression and
NHE-dependent acid extrusion are upregulated during TGFβ-1-induced EMT of Panc-1
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cells. NHE1 upregulation is SMAD4-dependent, and SMAD4-deficient BxPC-3 cells
show no change in pHi regulation. NHE1 and NBCn1 are not required for EMT per
se or EMT-associated proliferation changes, but are essential for the potentiation of
invasiveness induced by Merlin knockdown.
Keywords: NHE1, SLC9A1, NBCn1, SLC4A7, Merlin, proliferation, invasion, PDAC
INTRODUCTION
Pancreatic ductal adenocarcinoma (PDAC) is one of the most
devastating cancers globally (1). The exceedingly poor prognosis
for PDAC patients reflects a combination of late detection,
rapid local invasiveness, and a severe lack of reliable biomarkers
and efficacious treatment schemes (2). PDAC is associated with
extensive metabolic changes, and PDAC tumors are accordingly
highly acidic (3). While PDAC genotypes are highly complex,
the most widely characterized driver mutations are activating
KRAS mutations, inactivating p53 tumor suppressor mutations,
and inactivation or loss of the cyclin-dependent kinase inhibitor
2A (CDKN2A, P16INK4) and the transforming growth factor β
(TGF-β) effector, SMAD4 (4, 5).
TGFβ signaling involves the binding of a TGFβ dimer (TGFβ-
1,−2, or−3, of which TGFβ-1 is most ubiquitous) to the
TGFβ receptor types I and II (TGFβRI and –II; the former
also known as ALK5). This results in formation of a hetero-
tetrameric receptor complex, where TGFβRII phosphorylates
and activates TGFβRI. TGFβRI in turn phosphorylates the
transcription factors SMAD2/3, which bind to the co-SMAD,
SMAD4, to form a hetero-trimeric protein complex that enters
the nucleus to control gene expression. This complex may further
interact with a variety of other transcription factors, which are
necessary cofactors for SMAD-dependent gene regulation (6, 7).
TGFβ ligands also signal through SMAD-independent pathways,
including mitogen-activated protein kinases, small GTPases, and
the phosphatidyl-inositol-3-kinase (PI3K)-AKT-mTOR pathway
(6, 7).
In non-cancer epithelial cells and in premalignant cells,
TGFβ signaling is consistently cytostatic, blocking cell cycle
progression by increased expression of cyclin-dependent kinase
(CDK) inhibitors. However, in many cancer cells, this is
overridden by strong CDK activation by other pathways,
causing TGFβ to be pro-tumorigenic (6). Accordingly, TGFβ
signaling has been shown to stimulate cell motility, invasion,
and proliferation, and limit antitumor immune response,
and TGFβRI inhibition can revert these effects (8–10). Both
pro- and antitumorigenic, highly genotype-dependent roles of
TGFβ signaling were demonstrated in PDAC cells (4, 11–13).
Illustrating the importance of TGFβ signaling in this cancer, a
recent study showed that almost 50% of PDAC patient tumors
exhibited mutations in TGF-β signaling components. While
SMAD4 inactivating mutations are most common, mutations in
SMAD3, TGFβ receptor type I (TGFBR1) and−2 (TFGBR2) are
also reported (4).
TGFβ signaling is a major driver of epithelial-to-mesenchymal
transition (EMT), a process with key roles in metastasis and
chemotherapy resistance (6, 8, 11, 14–16). In PDAC, TGFβ-
induced EMT has been reported to involve SMAD4-dependent
(17) and -independent (18) signaling, however, the process is
incompletely understood.
Solid tumors are characterized by an often profoundly
acidified extracellular pH (pHe), a neutral or slightly increased
intracellular pH (pHi), and a greatly increased rate of acid
extrusion (19, 20). The latter occurs because the acid generated
by the high, predominantly glycolytic, metabolism of tumor cells
is actively extruded from the cancer cells by specific transporters.
These transporters, including the Na+/H+ exchanger NHE1
(SLC9A1) and the Na+, HCO−3 cotransporters NBCn1 (SLC4A7)
and NBCe2 (SLC4A5) confer additional advantages to the
cancer cells, including stimulation of proliferation, survival, and
invasiveness, leading to increased tumor growth and metastasis
(21–24). In particular NHE1 is important for cell motility
and invasiveness, which are key downstream events in EMT
(25). Directly implying a link to TGFβ, NHE1 is implicated in
fibronectin release in a manner rescued by TGFβ-1 (26).
We therefore hypothesized that net acid extruding proteins
are regulated by TGFβ signaling in human PDAC cells and
contribute to its downstream effects. We here show that TGFβ-1-
induced EMT of Panc-1 cells is associated with increased protein
levels of NHE1 and NBCn1 as well as increased pHi, whereas
smaller changes were observed in SMAD4-deficient BxPC-3 cells,
which show only a verymodest EMT. This difference between the
two cell lines is corroborated in the opposite effects of TGFβ-1
on proliferation, which is increased in Panc-1 and decreased in
BxPC-3 cells. Furthermore, knockdown of the tumor suppressor
Merlin potentiates TGFβ-1-induced Panc-1 cell invasiveness in a
manner dependent on both NHE1 and NBCn1. We propose that
acid-extruding transporters are novel players in TGFβ-1-induced
EMT in PDAC cells.
MATERIALS AND METHODS
Antibodies and Reagents
Primary antibodies used in western blot analysis were: mouse
anti-β-actin, mouse anti-α-tubulin, and mouse anti-α-smooth
muscle actin (α-SMA), all from Sigma-Aldrich; goat polyclonal
anti-CTGF and mouse anti-NHE1 (clone 54), anti-Poly-ADP
Ribose Polymerase (PARP), anti-cleaved PARP (Asp214) and
anti-pSer807/811-Rb, all from Santa Cruz Biotechnology; mouse
anti-dynactin 1 (DCTN1) and mouse anti-E-cadherin, from
BD Biosciences; rabbit anti-GAPDH, rabbit anti-Histone 3,
rabbit anti-Merlin, mouse anti-p53, mouse anti-Ki67, and rabbit
anti-β-catenin, all from Cell Signaling. Mouse anti- Ki-67
was from Dako (Glostrup, Denmark) and rabbit polyclonal
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anti-NBCn1 was a kind gift from Jeppe Prætorius, Aarhus
University, Denmark. Secondary antibodies used in western
blotting were horseradish-peroxidase-conjugated goat polyclonal
anti-mouse or anti-rabbit and rabbit polyclonal anti-goat from
Dako. Secondary antibodies for immunofluorescence analysis
were AlexaFluor488-conjugated donkey anti-mouse or anti-
rabbit, and AlexaFluor568-conjugted donkey anti-mouse or
anti-rabbit, all from Invitrogen. Recombinant human TGFβ-
1 (PHG9214) was from Life Technologies. Mouse monoclonal
antibody against Proliferating cell nuclear antigen (PCNA) was
from Cell Signaling Technology.
Cell Culture
Human PDAC cell lines MIAPaCa-2, Panc-1, BxPC-3, and
AsPC-1 were acquired from American Type Culture Collection
(ATCC, Rockville, MD, USA) and maintained in RPMI medium
1640+GlutaMAXTM-I or Dulbecco’s Modified Eagle’s medium
(DMEM)+GlutaMAXTM-I (both from Gibco) supplemented
with 10% (v/v) fetal bovine serum and 100 U/ml penicillin and
100µg/mL streptomycin at 37◦C in a humidified atmosphere
of 5% CO2. MIAPaCa-2 cell medium was further supplemented
with 2.5% (v/v) heat-inactivated horse serum. Immortalized
human pancreatic ductal epithelial (HPDE H6c7) cells were a
kind gift from Dr. Ming-Sound Tsao at Ontario Cancer Institute,
Toronto, Canada (27, 28) and were cultured in kerantinocyte
basal medium supplemented with epidermal growth factor and
bovine pituitary extract.
siRNA-Mediated Knockdown
siRNAs employed were: NHE1 siRNA: ON-TARGET SMART
pool (Thermo Scientific); NBCn1 siRNA (SASI_Hs01_00030755,
Sigma-Aldrich) sense sequence 5′-CAUUAACUGGGAUUG
CCUA-3′, Merlin siRNA (SASI_Hs_01_00188862, Sigma) sense
sequence 5′-CCUCAAAGCUUCGUGUUAA-3; SMAD4
(EHU018671 esiRNA siRNA mixture, Sigma). A 19-bp
scrambled oligomer (sense: 5′-AGGUAGUGUAAUCGC
CUUG-3′) (Eurofins MWG Operon, Ebersberg, Germany)
was used for mock transfection. Cells were seeded to ∼40%
confluency in the relevant culture dishes and transfected
with NHE1 siRNA (100 nM), NBCn1 siRNA (25 nM),
Merlin siRNA (50 nM) or mock siRNA (50 nM), using
Lipofectamine (Invitrogen) transfection reagent, according
to the manufacturer’s specifications. 48 h after transfection, cells
were serum starved, and 24 h later, exposed to TGFβ treatment
(or corresponding control conditions) for another 48 h before
analysis for the relevant experiment as indicated below.
RT-qPCR Analysis
Total RNA was isolated using NucleoSpin R© RNA II (Macherey-
Nagel, Germany) according to the manufacturer’s instructions,
reverse-transcribed using Superscript III Reverse Transcriptase
(Invitrogen, Carlsbad, CA) and cDNA transcripts were amplified
by qPCR using the SYBR Green technique (Applied Biosystems,
Cheshire, UK). Amplification was performed in triplicate
in an ABI7900 qPCR machine, using 40 cycles of (95◦C for
30 s, 60◦C for 1min, 72◦C for 30 s). Primer sequences were:
NHE1-fw: 5′-CACACCACCATCAAATACTTCC-3′, NHE1-rv:
5′-GAACTTGTTGATGAACCAGGTC-3′; NHE2-fw: TTG
GAGAGTCCCTGCTGAATGATG, NHE2-rv: tcagctgtgatgt
aggacaaataactg, NBCn1-fw: 5′-GCAAGAAACATTCTGACC
CTCA-3′, NBCn1-rv: 5′-GCTTCCACCACTTCCATTACzCT,
NBCe2-fw: atcttcatggaccagcagatcac, NBCe2-rv: tgcttggctggcatc
aggaag. mRNA expression was quantified using the comparative
threshold cycle (Ct) method, using β-actin as reference gene
(fw 5′- AGCGAGCATCCCCCAAAGTT-3′, rv 5′-GGGC
ACGAAGGCTCATCATT-3′), and is given relative to that in
HPDE cells.
SDS-PAGE and Western Blotting
Cells were seeded to 60–70% confluency in 6-well culture dishes,
lysed in lysis buffer [1% SDS, 10mM Tris-pH 7.5, Na3VO4
1mM, and complete protease inhibitor cocktail (Roche)] and
homogenized by sonication. SDS-PAGE was performed using
Bio-Rad CriterionTM TGXTM precast 10% gels in Tris/Glycine
buffer. Gels were run for 1 h at 150V, followed by transfer to
Trans-Blot R© TurboTM 0.2µm nitrocellulose membranes (Bio-
Rad). Protein transfer was evaluated by Ponceau red staining,
followed by blocking in 5% dry milk in TBST (0.01M Tris/HCl,
0.15M NaCl, 0.1% Tween 20) for 30min at room temperature,
incubation with primary antibodies overnight at 4◦C, and
finally washing in TBST and incubation with HRP-conjugated
secondary antibodies for 2 h at room temperature. Blots were
developed using the FUSION-Fx chemiluminescence system
(Vilber Lourmat). Images were processed in Adobe Photoshop
and band intensities were quantified using UN-SCAN-IT gel
6.1 software.
Immunofluorescence Microscopy Analysis
Cells were grown on glass coverslips in 6-well culture dishes, fixed
in 4% paraformaldehyde for 15min at room temperature, washed
in icecold PBS, and permeabilized for 12min in permeabilization
buffer (0.2 % Triton X-100, 1% BSA in PBS). Unspecific
fluorescence was blocked by a 30min incubation in PBS plus
2% BSA, followed by incubation with primary antibody for
1½ h at room temperature, three washes in 2% BSA blocking
buffer, and incubation with secondary antibodies diluted in 2%
BSA blocking buffer) for 45min, washing in PBS containing 2%
BSA, a 5min incubation with (4’,6-Diamidino-2-Phenylindole,
Dihydrochloride) (DAPI) for nuclear staining, extensive washing
in PBS and mounting in N-propyl-gallate mounting media (2%
w/v in PBS/glycerin). Fluorescence images were captured on
a fully motorized Olympus BX63 upright microscope with an
Olympus DP72 color, 12.8-megapixel, 4.140 × 3.096-resolution
camera and with a fully motorized and automated Olympus IX83
Inverted microscope with a Hamamatsu ORCA-Flash 4.0 camera
(C11440-22CU). The software used was Olympus CellSens
dimension, which is able to do deconvolution on captured z
stacks, and images were processed for publication using Adobe
Photoshop CS6.
Real-Time Imaging of Intracellular pH
Measurements of pHi were carried out essentially as described
previously (21). Briefly, cells seeded in WillCo glass-bottom
dishes (WillCo Wells, Amsterdam, the Netherlands) were loaded
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with 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein
acetoxymethyl ester (BCECF-AM, 1.6µM) in growth medium
for 30min at 37◦C. Cells were washed once in HCO−3 containing
Ringer solution [118mM NaCl, 25mM NaHCO3, 5mM
KCl, 1mM MgSO4, 1mM Na2HPO4, 1mM CaCl2, 3.3mM
3-(N-morpholino)propanesulfonic acid (MOPS), 3.3mM 2-
[Tris(hydroxymethyl)-methylamino]-ethanesulfonic acid (TES),
5mM HEPES, pH 7.4], placed in a 37◦C imaging chamber
equipped with gas and solute perfusion, at the stage of a Nikon
Eclipse Timicroscope, and imaged using a 40X/1.4 NA objective
and EasyRatioPro imaging software (PTI, NJ, USA). Emission
was measured at 520 nm after excitation at 440 and 485 nm.
Acidification was induced by exposure to 20mM NH4Cl for
10min. Calibration to pHi values was performed using the high
K+/nigericin technique and a 4-point linear calibration curve.
BrdU Proliferation Assay
Eighty percentage confluent Panc-1 and BxPC3 cells were
trypsinized and resuspended in growth medium. Cells were
seeded in 96-well plates (Celllstar R©, cat # 655090). After 24 h
incubation at 37◦C/5% CO2, plates were washed in PBS and
200 µl serum free medium was added. After 24 h, the cells were
incubated with 10 ng/mL TGFβ, and/or 10µM of the NHE1
inhibitor cariporide. Forty-eight hours later, a Cell Proliferation
ELISA, BrdU (chemiluminescent) kit (Roche, cat # 11 669 915
001) was used for determining the proliferation status of the cells,
according to the manufacturer’s instructions. 20µl BrdU labeling
solution was added to each well and the plates were incubated for
4 h, followed by a fixation/denaturing step, and incubation with a
peroxidase-coupled mouse monoclonal anti-BrdU antibody. The
plates were washed extensively, incubated with substrate solution
containing luminol, 4-iodophenol and peroxide for 4min on
a shaker, and luminescence measured using a BMG FLUOstar
OPTIMAMicroplate Reader.
Invasion Assay
Cell invasion was assessed using growth factor reduced corning R©
Matrigel R© invasion chambers, 24-well plate and 8.0µm pore size
(Corning, BioCoat, MA, USA). Prior to the experiment, invasion
chambers containing Matrigel were rehydrated by adding 500
µl serum free medium for 2 h at 37◦C. Forty-eight hours after
transfection with the indicated siRNAs, cells were serum starved,
and 24 h later, treated or not with TGFβ for 48 h, before being
washed with sterile PBS, trypsinized, washed 3 x in serum
free medium, and 50,000 cells in this medium seeded into the
upper chamber. Experiments were always done in duplicate. The
lower chamber was filled with 10% serum containing medium.
Chambers were incubated for 22 h at 37◦C/5% CO2 to allow
cells to invade through the Matrigel. Non-invaded cells from
the upper surface of the chamber were removed with a cotton
swab. Invaded cells on the lower surface of the chamber were
fixed for 30min in ice-cold absolute methanol, and filters were
stained with 30% Giemsa solution (Sigma-Aldrich) for 30min
and mounted on glass slides. Invaded cells (four images per filter
per condition) were counted using bright-field microscopy.
Data Analysis and Statistics
Data are shown as individual representative experiments or as
means of at least three independent experiments, with standard
error of mean (SEM) error bars. Statistical significance was
tested using Student t-test or one- or two-way ANOVA followed
by Tukey’s multiple comparison tests as appropriate, using
GraphPad prism 6.
RESULTS
Expression of Net Acid Extruding
Transporters Is Increased in PDAC Cells
Our previous in silico analysis of RNA sequencing data from
pancreatic cancer patient tissue indicated that a number of
SLC9 and SLC4 family transporters are upregulated in PDAC
patient tumor tissue compared to normal pancreatic epithelium
(29). From these, we selected for widely expressed net acid
extruders for initial analyses: two Na+/H+ exchangers, NHE1
and−2 (SLC9A1-2), and twoNa+,HCO−3 cotransporters (NBCs),
NBCe2 (SLC4A5) and NBCn1 (SLC4A7). The relative mRNA
levels of the transporters were determined by RT-qPCR analysis
in immortalized pancreatic epithelial (HPDE) cells (27, 28), and
in a panel of human PDAC cell lines of different genotypes:
MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 cells. All PDAC
cell lines studied exhibited increased mRNA levels of one or
more of these transporters compared to HPDE cells, with
the specific transporters upregulated differing between cell
lines (Figures 1A,B). Thus, BxPC-3 and AsPC-1 cells showed
elevated expression of NHE1 and−2, and MIAPaCa-2 cells
predominantly showed upregulation of NBCn1 and NBCe2,
while both NHE2 and NBCn1 were upregulated in Panc-1
cells. For further analyses, we focused on NHE1 and NBCn1,
which play central roles in the development of PDAC and other
cancers (21, 22, 24, 30–33). Consistent with the mRNA data,
western blot analysis revealed that the NHE1 protein level was
significantly increased in BxPC-3 cells and the NBCn1 protein
level in MIAPaCa-2 and Panc-1 cells, compared to that observed
in HPDE cells (Figures 1C,D).
These data show that net acid extruding proteins are
upregulated in PDAC cells compared to normal pancreatic ductal
epithelial cells, and that the specific pattern of upregulation is cell
type dependent.
TGFβ-1 Treatment Elicits a
SMAD4-Dependent EMT in PDAC Cells
BxPC-3 and Panc-1 cells, which display a high levels of NHE1
and NBCn1 expression, respectively, were chosen for further
analysis. We first assessed the ability of TGFβ ligand to induce
EMT in the two cell lines. Cells were serum-starved for 24 h,
followed by treatment with 10 ng/ml human recombinant TGFβ-
1 for 48 h. After lysis, cells were subjected to western blot analysis
for the epithelial marker E-cadherin as well as the mesenchymal
markers α-smooth muscle actin (α-SMA) and connective tissue
growth factor (CTGF) (Figure 2A). In Panc-1 cells, TGFβ-1
treatment significantly reduced the level of E-cadherin, and
increased that of α-SMA and CTGF, consistent with induction of
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FIGURE 1 | mRNA and protein expression of net acid extruding transporters is upregulated in PDAC cells compared to normal pancreatic ductal epithelial cells. (A,B)
Immortalized pancreatic ductal epithelial (HPDE) cells and a panel of PDAC cell lines: MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 cells, were grown to about 80%
confluence, lysed and mRNA expression of NHE1 and−2 (A) and NBCe2 and NBCn1 (B) analyzed by RT-qPCR. Data (mean with S.E.M. error bars) are normalized to
the expression level in HPDE cells in the same experiment (shown as a dotted line). (C,D) HPDE, MIAPaCa-2, Panc-1, BxPC-3, and AsPC-1 cells were grown to
about 80% confluence, lysed and protein levels of NHE1 (C) and NBCn1 (D) analyzed by Western blotting. Data (mean with S.E.M. error bars) are normalized to the
β-actin loading control and to the expression level in HPDE cells in the same experiment (shown as a dotted line). n = 3–4 independent experiments per condition in
all panels. *, ** One-way ANOVA, p < 0.05 and 0.01, respectively, against the level in HPDE cells.
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EMT (Figures 2A,B). In BxPC-3 cells, TGFβ-1 treatment elicited
a small yet significant decrease in E-cadherin of about 25%,
which was not accompanied by detectable changes in α-SMA and
CTGF expression (Figures 2A,C). Immunofluorescence analysis
was performed to assess the impact of TGFβ-1 treatment on
cell morphology and protein localization in Panc-1 cells. TGFβ-1
treatment induced a marked internalization of both E-cadherin
and β-catenin (arrows), a strong, predominantly membrane-
associated increase in α-SMA, and increased intracellular CTGF
expression (Figure 2D).
These data show that TGFβ-1 treatment elicited a marked
EMT in Panc-1 cells, and a modest and partial EMT in BxPC-
3 cells.
BxPC-3 cells are SMAD4-deficient (34), which has previously
been shown to be responsible for their partial resistance to
TGFβ-1-induced EMT (14), although the absolute requirement
for SMAD4 for TGFβ-1-induced EMT is controversial (14, 35).
To assess the role of SMAD4 in TGFβ-1-induced EMT in
Panc-1 cells, we knocked down SMAD4 by siRNA in Panc-
1 cells, followed by TGFβ-1 treatment for 48 h, and western
blotting for E-cadherin and CTGF (Figures 2E–H). In mock-
transfected cells, TGFβ-1 treatment almost doubled the level of
SMAD4. Confirming efficient knockdown, the SMAD4 protein
level was reduced by more than 80% in SMAD4 siRNA-treated
cells (Figures 2E,F). Notably, the E-cadherin level was more
than doubled by SMAD4 knockdown in the absence of TGFβ-
1, and this was only marginally reduced by TGFβ-1-induced
increase in CTGF expression was abolished in SMAD4-depleted
cells (Figure 2G). Conversely, SMAD4 knockdown had no effect
on the CTGF level under control conditions yet abolished the
increase in CTGF induced by TGFβ-1 treatment (Figure 2H).
Collectively, these data show that TGFβ-1 induced EMT in
Panc-1 cells is strongly dependent on SMAD4 and suggest that
a basal level of SMAD4 signaling in the absence of TGFβ-1
treatment is responsible for the low basal E-cadherin level in
these cells.
NHE1 Expression Is Increased in a
SMAD-Dependent Manner During
TGFβ-1-Induced EMT
We next asked whether TGFβ-1 treatment altered NHE1 and
NBCn1 expression in Panc-1 and BxPC-3 cells. The protein
expression level of NHE1 increased by about 60%, and that of
NBCn1 by about 40%, following TGFβ-1 treatment of Panc-1
cells (Figures 3A,B), and a similar, albeit non-significant trend
was seen in BxPC-3 cells (Figures 3A,C). The mRNA level of
NHE1 also tended to be upregulated by TGFβ-1 in Panc-1 cells,
and that of NBCn1 in BxPC-3 cells (Figures 3C,D). The TGFβ-
1-induced increase in NHE1 expression was strongly reduced
by SMAD4 knockdown in Panc-1 cells (Figures 3E,F), whereas
the modest increase in NBCn1 expression was not affected by
SMAD4 knockdown (Figures 3E,G). This suggests that increased
NHE1 expression is mainly mediated by canonical TGFβ
signaling, whereas the effect of TGFβ-1 on NBCn1 expression
appears to be mediated by non-canonical signaling events. Both
transporters localize predominantly to the plasma membrane
in both cell types. Interestingly, TGFβ-1 treatment caused a
characteristic redistribution of NBCn1 to membrane ruffles
in BxPC-3 cells (Figure 3I) whereas there was no detectable
redistribution in Panc-1 cells (Figure 3H).
To determine whether NHE1 and NBCn1 played a role in the
EMT process per se, we knocked down each transporter in Panc-1
cells and subjected the cells to 48 h of TGFβ-1 treatment as above,
followed by western blotting for E-cadherin and CTGF. Although
the protein level of both transporters was essentially abolished
upon siRNA treatment, this did not detectably affect TGFβ-
1–induced E-cadherin downregulation or CTGF upregulation
(Supplementary Figure 1).
These results show that TGFβ-1 induced EMT is associated
with increased expression of NHE1 and NBCn1 and increased
localization of the transporters at the plasma membrane where
they could increase net acid extrusion from the cells. However,
neither transporter is required for induction of EMT per se.
TGFβ-1 Increases Steady State pHi and
NHE1-Dependent Acid Extrusion in Panc-1
Cells
To directly determine whether the changes in transporter
expression upon TGFβ-1-induced EMT are associated with
altered pHi homeostasis, cells were subjected to TGFβ-1
treatment for 48 h, loaded with the pHi sensitive fluorophore
BCECF-AM, and steady state pHi determined by live imaging
of BCECF fluorescence. Experiments were carried out in
the presence of CO2/HCO
−
3 to allow contributions from
bicarbonate-dependent transporters such as NBCn1. TGFβ-1
treatment significantly increased steady state pHi in Panc-1 cells,
from an average value of 7.06 ± 0.105 in control cells to 7.26
± 0.043 after TGFβ-1 treatment (Figure 4A). In contrast, the
steady state pHi of BxPC-3 cells was 7.01± 0.062 in controls and
7.09 ± 0.066 after TGFβ-1 treatment, not significantly different
(Figure 4B).
To evaluate whether cellular capacity for acid extrusion was
increased by TGFβ-1 treatment, we next determined the pHi
recovery rate. Cells were pretreated with or without TGFβ-1 for
48 h as above, and subjected to an NH4Cl-prepulse to acidify the
cells: after equilibration in normal CO2/HCO
−
3 saline, cells were
perfused with 15mM NH4Cl. Upon dissociation, NH3 rapidly
enters the cells by diffusion. Its association with cellular H+
to NH+4 causes near-instantaneous alkalinization, followed by
slow return toward steady state pHi as NH
+
4 from the solution
enters the cells via ion transporters, shifting the equilibrium.
When cells are again perfused with normal CO2/HCO
−
3 saline,
all NH3 rapidly diffuses out, and an excess of free H
+ is left
in the cells. The rate of recovery from this acidification is a
measure of net acid extrusion capacity, determined as the slope
of the initial, linear part of the curve under conditions where
starting pHi is similar (36). Experiments were again carried out in
the presence of CO2/HCO
−
3 . Figures 4C,D shows representative
traces of pHi over time from the maximal acidification. As seen,
TGFβ-1 treatment markedly increased the pHi recovery rate in
Panc-1 cells (Figure 4C) but not in BxPC-3 cells (Figure 4D).
NHE1 and NBCn1 activity is posttranslationally regulated (37,
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FIGURE 2 | TGFβ-induces a predominantly SMAD4-dependent EMT. (A) Panc-1 and BxPC-3 cells were serum starved for 24 h, followed by 48 h growth with or
without 10 ng/ml human recombinant TGFβ-1 for 48 h as indicated. Cells were lysed and subjected to western blotting for E-cadherin, α-SMA, and CTGF, using
GAPDH and DCTN1 as loading markers. Representative western blots are shown. (B,C) Summarized, quantified data from experiments as in (A), for Panc-1 cells (B)
and BxPC-3 cells (C). Data (mean with S.E.M. error bars) were normalized to loading control and to the level in the absence of TGFβ-1 (Ctrl.), shown by the dotted
line. n = 3–8 independent experiments per condition. *, **, **** One-way ANOVA, p < 0.05, 0.01, 0.0001, respectively, against the level in non-TGFβ-1 treated control
cells. (D) Immunofluorescence microscopy analysis of the localization and expression level of E-cadherin, β-catenin, α-SMA and CTGF in Panc-1 cells. Nuclei are
stained using DAPI. The images shown are representative of at least three independent experiments per condition. Arrows indicate the distinct plasma membrane
localization of E-cadherin and β-catenin under control conditions and the shift in localization upon TGFβ-1 treatment. (E–H) Effect of SMAD4 knockdown in Panc-1
(Continued)
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FIGURE 2 | cells on E-cadherin and CTGF protein levels. E, representative western blot, F-H, SMAD4, E-cadherin, and CTGF protein levels, normalized to mock ctrl.
and shown as mean with S.E.M. error bars and individual data points. Relative to mock siRNA-treated controls, SMAD4 expression was 1.8 ± 0.55 in mock siRNA +
TGFβ-1 treated cells, 0.18 ± 0.066 in SMAD4 siRNA treated cells, and 0.18 ± 0.063 in SMAD4 siRNA + TGFβ-1 treated cells. β-actin and Histone 3 (H3) are used as
loading markers. Data are from four independent experiments per condition. *, ** One-way ANOVA, p < 0.05, 0.01, respectively.
38), hence, their contributions to pHi regulation are not predicted
by their protein levels. Notably, in both Panc-1 and BxPC-3
cells, pHi recovery in both control- and TGFβ-1 treated cells was
abolished by the specific NHE1 inhibitor cariporide regardless of
(Figures 4E,F).
Collectively, these results show that TGFβ-1-induced EMT in
Panc-1 cells is associated with increased steady state pHi and
increased NHE1-dependent acid extrusion capacity.
TGFβ-1 Differentially Regulates Cell
Proliferation in Panc-1 and BxPC-3 Cells
Depending on the cell type and context, TGFβ signaling can
counteract or stimulate cell proliferation, and this has been
ascribed at least in part to SMAD2/3 signaling, which rely on
SMAD4 (4, 6). We therefore assessed the impact of TGFβ-
1 treatment on cell proliferation in Panc-1 and BxPC-3 cells.
Cells treated for 48 h with or without TGFβ-1 were lysed and
blotted for phosphorylated retinoblastoma protein (p-pRb) and
proliferating cell nuclear antigen (PCNA) as markers of cell cycle
entry and progression, respectively. Notably, TGFβ-1 treatment
increased the p-pRb level in Panc-1 cells yet decreased it in
BxPC-3 cells (Figures 5A,B), and similar results were obtained
for PCNA (Figures 5A,C). This was confirmed by IFM analysis
using Ki-67 as a proliferation marker: The fraction of Ki-67
positive cells was decreased in both cell types—although most
dramatically in Panc-1 cells—by 48 h of serum starvation, and
was increased in Panc-1 cells, yet decreased in BxPC-3 cells
by TGFβ-1 (Figures 5D–F). Strikingly, TGFβ-1 treatment also
increased p53 expression in Panc-1 cells, but not in BxPC-3 cells
(Figure 5G). Co-staining for p53 and p-pRb confirmed these data
and revealed that elevation of nuclear staining for p-pRb and p53
was detected within the same cells (Supplementary Figure 2).
BrdU incorporation analysis confirmed that TGFβ-1 treatment
increased proliferation of Panc-1 cells, yet decreased that of
BxPC-3 cells, and showed that proliferation was unaffected by
inhibition of NHE1 (10µM cariporide) or NBCs (10µM S0859),
under both basal and TGFβ-1-treated conditions (Figures 5H,I).
Taken together, these results show that TGFβ-1 treatment
stimulates proliferation of Panc-1 cells yet inhibits that of BxPC-
3 cells. This occurs in parallel with a TGFβ-1-induced increase in
p53 expression in the Panc-1 cells and is unaffected by inhibition
of NHE1 or NBCn1.
Loss of Merlin Stimulates TGFβ-1-Induced
Invasiveness in an NHE1- and
NBCn1-Dependent Manner
Previous studies have demonstrated the involvement of acid-base
transporters in cell motility and invasiveness, through roles of the
transporters in cell adhesion, cytoskeletal dynamics,and matrix
degradation (19, 25, 39–41). We therefore asked whether the
TGFβ-1-induced upregulation of NHE1 and NBCn1 contributed
to TGFβ-1-induced invasiveness of Panc-1 cells.
Stimulation with TGFβ-1 increased invasion of Panc-1 cells
through Matrigel more than 4-fold (Figure 6B), consistent
with the strong TGFβ-1-induced EMT induction in these
cells (Figure 2). siRNA-mediated knockdown of NHE1
further increased TGFβ-1-induced invasiveness, whereas
knockdown of NBCn1 or both transporters in combination
had no effect (Figures 6A,B). The unexpected exacerbation
of invasiveness by NHE1 knockdown prompted us to ask
whether the impact of NHE1 on PDAC cell invasiveness
was genotype-dependent. The tumor suppressor Merlin (aka
Neurofibromatosis type 2, NF2), which is downregulated
in many PDAC tumors (42), was reported to regulate EMT
(43) and cell motility (44), and was recently shown to
regulate NHE1 in melanoma cells (45). siRNA-mediated
knockdown of Merlin (Figure 6A) increased basal invasion
4-fold and almost doubled TGFβ-1-induced invasiveness
(Figure 6C). Notably, in Merlin-depleted cells, knockdown
of either NHE1 or NBCn1 abolished the increase in invasion
(Figure 6C).
These results show that Merlin depletion increases basal
invasion and potentiated TGFβ-1-induced invasiveness. Invasion
induced by Merlin depletion, but not that induced by TGFβ-1
alone, is dependent on NHE1 and NBCn1.
DISCUSSION
Pancreatic cancer has one of the most ominous mortality
rates of any cancer globally, and the relative burden of
disease is expected to increase over the next decade (1).
PDAC tumors frequently exhibit abundant secretion of
TGFβ from both stromal and tumor cells (46). Another
characteristic of PDAC is extensive EMT (14, 15), the
roles of which in PDAC development are incompletely
understood (11, 16).
An emerging hallmark of solid tumors is profound
dysregulation of pH homeostasis and upregulation of net
acid-extruding transport proteins which play important roles
in cancer development (19, 20). Given the extreme acid-base
homeostasis of the pancreas under physiological conditions
(3), PDAC is particularly interesting in this context. Here,
we asked whether TGFβ-1-induced EMT in PDAC cells is
associated with upregulation of net acid extruding transporters.
We focused on NHE1 and NBCn1, which we and others have
shown to play important roles in cancer development (21–24),
and found that these transporters were upregulated in PDAC
cell lines compared to normal controls. The great majority of
patient PDAC tumors show activating KRAS mutations, and
about 50% show mutations in TGFβ pathway components,
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FIGURE 3 | NHE1 and NBCn1 protein expression is upregulated during TGFβ-induced EMT. (A,B) Following growth in absence or presence of 10 ng/ml human
recombinant TGFβ-1 for 48 h, cells were lysed and subjected to western blotting for NHE1 and NBCn1. (A) representative blots, with GAPDH and α-tubulin as loading
markers. (B) quantified data for Panc-1 and BxPC-3 cells, shown as mean with S.E.M. error bars, normalized to the level in absence of TGFβ-1 (represented by the
dotted line). Data shown represent n = 3–8 per condition. * One-way ANOVA, p < 0.05, against the level in non-TGF-β treated control cells. (C,D) Panc-1 (C) and
BxPC-3 (D) cells were serum-starved for 24 h, followed by TGFβ-1 treatment as above for 48 h. mRNA levels were determined by qPCR and normalized to
(Continued)
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FIGURE 3 | non-TGF-β treated control cells. Data are mean with S.E.M. error bars, of 8-11 independent experiments per condition. (E–G) Effect of SMAD4
knockdown on NHE1 and NBCn1 protein levels in Panc-1 cells. (E) representative western blot, (F,G) NHE1 and NBCn1 protein levels, normalized to mock ctrl. and
shown as mean with S.E.M. error bars and individual data points. Data shown are from 4 independent experiments per condition. For SMAD4 knockdown efficiency,
see Figure 2E and Figure 2 legend. **, *** One-way ANOVA, p < 0.05, 0.01, respectively. (H,I) IFM analysis illustrating the localization and expression level of native
NHE1 (red) and NBCn1 (green) in Panc-1 (H) and BxPC-3 (I) cells. Nuclei are stained using DAPI. Images shown represent at least three independent experiments per
condition. Scale bars are 20µm, and 10 µm in the zoomed images.
most commonly SMAD4 loss or inactivating mutations (4).
For further analysis we therefore selected Panc-1 cells, which
harbor an activating KRAS mutation and express wild type
SMAD4, and BxPC-3 cells, which are KRAS wild type and
express a truncated, defective version of SMAD4 (34). Consistent
with previous reports (14, 15, 35), 48 h TGFβ-1 treatment
robustly induced EMT characteristics, i.e., downregulation
of E-cadherin, upregulation of α-SMA and CTGF, and
internalization of β-catenin in Panc-1 cells, compared to a
partial EMT in BxPC-3 cells where only E-cadherin expression
was detectably altered. Accordingly, SMAD4 knockdown in
Panc-1 cells largely abolished EMT. EMT has been reported
to involve both SMAD4-dependent (17) and–independent
(18) processes. TGFβ-induced E-cadherin downregulation
in Panc-1 cells and other PDAC cell lines was reported to
be nearly completely dependent on SMAD3 and SMAD4,
as well as the EMT-associated transcription factors SLUG
and SNAIL, which are activated downstream from SMAD4
(35). The SMAD3-4 complex binds and activates the SNAIL
promoter, in turn leading to the SNAIL-dependent E-cadherin
downregulation (47). However, non-canonical TGFβ pathways
including ERK1/2 were also reported to contribute to EMT (35),
consistent with our finding of partial EMT induction in BxPC-3
cells (34).
A central finding of this work was that TGFβ-1-induced
EMT was associated with upregulation of NHE1, and to a lesser
extent NBCn1, expression in Panc-1 cells. Consistent with this,
NHE1 was recently proposed to be upregulated by ZEB1, a
transcription factor involved in driving EMT (48). Knockdown
of the NHE1 or NBCn1 had no detectable effect on EMT
induction per se (E-cadherin, CTGF and α-SMA levels). However,
in congruence with the transporter upregulation, EMT induction
was associated with an increase in steady state pHi and increased
capacity for net acid extrusion in Panc-1 cells but not in BxPC-
3 cells. Acid extrusion was potently inhibited by the NHE1
inhibitor Cariporide in both cell lines, despite the presence of
CO2/HCO
−
3 and the relatively high expression of NBCn1 in the
Panc-1 cells. Both cell lines also express NHE2 at rather high
levels (Figure 1A). With reported Ki values for Cariporide of
0.05µM for NHE1 and 3µM for NHE2 in transfected fibroblasts
(49), it seems likely that both isoforms might contribute to
this recovery (see also below). Notably, the stimulatory effect
of TGFβ on pHi regulation in Panc-1 cells differs from the
reported inhibitory effect of TGFβ on pHi regulation in non-
cancer hepatocytes (50). Thus, it appears that, fully in line
with the opposite effects of TGFβ signaling on proliferation
and survival in cancer- and non-cancer cells (6, 8), TGFβ
attenuates pHi regulation in normal cells, yet stimulates it in
some cancer cells.
TGFβ-1 treatment significantly increased proliferation of the
SMAD4-positive Panc-1 cells, while decreasing it in the SMAD4-
deficient BxPC-3 cells. Paradoxically, at the same time, TGFβ
treatment increased p53 expression in Panc-1 cells but not in
BxPC-3 cells. Thus, clearly, the presence of SMAD4 and TGFβ-
1-induced p53 signaling does not prevent a pro-proliferative
effect of the ligand. Both TGFβ and acid extruding proteins
are important regulators of cell proliferation/death balance, and
EMT has recently been recognized to play important roles also
in control of cancer cell survival (11, 16). We therefore reasoned
that transporter upregulation might regulate the balance between
pro-death and pro-growth effects of TGFβ in PDAC, yet,
inhibition of NHE1 or NBCs did not affect proliferation of either
cell line under these conditions. It remains possible that such
effects might be uncovered in the severely nutrient-deprived
and hypoxic tumor microenvironment, where NHE1 has been
proposed to play a role in nutrient uptake in PDAC cells via
macropinocytosis (51).
Given the roles of pHi and pHe in general, and NHE1 and
NBCn1 in particular, in cancer cell motility and invasion (19, 25,
39–41), we asked whether NHE1 and NBCn1 impacted TGFβ-
1-induced invasiveness. Forty-eight hours of TGFβ-1 treatment
robustly increased invasiveness of Panc-1 cells and this was not
abolished by transporter knockdown; in fact, siRNA-mediated
depletion of NHE1 modestly increased invasiveness, a finding
reminiscent of our demonstration that counter to its general
role in favoring motility and invasiveness (25), NHE1 inhibition
actually increased motility of p95HER-overexpressing breast
cancer cells, while inhibition of NBCs had no effect (52). The
lack of effect of NHE1 knockdown shown here contrasts the
conclusion of a recent report using 10µM cariporide to inhibit
NHE1 (32). Since NHE1 knockdown was highly efficient in our
study, it seems possible that the effect of cariporide may reflect
a contribution of NHE2, which, as noted above, would also
have been inhibited at this concentration. The tumor suppressor
Merlin exhibits reduced expression in PDAC patients (42, 53), is
regulated by TGFβ (54), has been assigned a role in regulation
of EMT in ARPE-19 cells (43), and in regulation of NHE1 in
melanoma cells (45). We therefore hypothesized that Merlin
depletion would impact TGFβ-1-induced invasiveness and its
regulation by NHE1 and NBCn1. Indeed, Merlin knockdown in
itself robustly increased invasiveness, and under these conditions,
knockdown of either NHE1 or NBCn1 decreased invasiveness, a
tendency seen under both basal and TGFβ-stimulated conditions.
This indicates that the roles of NHE1 and NBCn1 may be
particularly important in cancers with Merlin downregulation. It
is well documented that the roles of pH regulatory transporters in
invasion involve effects on focal adhesion strength and turnover,
cytoskeletal dynamics, and matrix degradation, downstream of
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FIGURE 4 | TGFβ-1 increases steady state pHi and NHE1-dependent acid extrusion in Panc-1 cells. Cells were treated ±10 ng/ml TGFβ-1 for 48 h, and intracellular
pH (pHi) was monitored by real-time imaging analysis in Panc-1 (A,C,E) and BxPC-3 (B,D,F) cells after loading of cells with BCECF-AM. Experiments were conducted
at 37◦C, and under CO2/HCO
−
3 buffered conditions. (A,B) Steady state pHi was increased by TGFβ-1 in Panc-1 but not in BxPC-3 cells. The graphs show the pHi in
paired control and TGFβ-1 treated cells from each experiment. The mean pHi values were, for Panc-1 cells, 7.06 ± 0.105 in control cells and 7.26 ± 0.043 after
TGFβ-1 treatment, and in BxPC-3 cells, 7.01 ± 0.062 in controls and 7.09 ± 0.066 after TGFβ-1. Data are based on 5 (Panc-1) and 6 (BxPC-3) independent
biological experiments for each condition. * significantly different, p < 0.05, paired t-test. (C–F) The pHi recovery rate was determined as the initial rate of recovery
after NH4Cl-prepulse-induced intracellular acidification. Where indicated, cariporide (10µM) was present during the recovery phase to inhibit NHE1. (C,D)
Representative traces with SD error bars, (E,F) means with S.E.M. error bars of 3–5 independent experiments per condition. **, *** Paired t-test, p < 0.01 and 0.001,
respectively against corresponding conditions (Ctrl, TGFβ) in absence of cariporide).
transporter-mediated changes in pHi and pericellular pHe (41).
While the precise roles of the transporters in Panc-1 cell invasion
were not further studied here, this is supported by the increased
pHi and acid extrusion capacity in TGFβ-stimulated Panc-1 cells
also demonstrated here.
A limitation of this study is that we did not study the
correlation of NHE1 and NBCn1 with EMT markers, TGFβ-
signaling pathway components, and Merlin expression in patient
tumor tissue from primary pancreatic tumors and metastases.
Future work should address such correlations to evaluate the
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FIGURE 5 | TGFβ-1 stimulates proliferation in Panc-1 cells, and inhibits it in BxPC-3 cells. (A) Panc-1 and BxPC-3 cells were serum starved for 24 h, followed by 48 h
growth with or without TGFβ-1 as indicated. Cells were lysed and blotted for p-pRb and PCNA, using GAPDH as loading marker. (B,C) Relative p-pRB and PCNA
levels from data as in (A). Data are normalized to ctrl. and shown as mean with S.E.M. error bars and individual data points. n = 3–5 per condition. *p < 0.05, paired,
two-tailed t-test, against the level in non-TGFβ-1 treated cells. (D,E) Immunofluorescence analysis of Ki-67 after 0 or 48 h of serum starvation, the latter ±TGFβ-1 as
shown. Ki-67 positive cells are quantified in (F). Data represent 3 independent experiments. (G) Panc-1 and BxPC-3 cells were serum starved for 24 h, grown for 48 h
with or without TGFβ, lysed and blotted for p53. n = 4. (H,I) Proliferation of Panc-1 (H) and BxPC-3 (I) cells determined by BrdU incorporation, in absence or
presence of NHE1 inhibitor cariporide (10µM) or NBC inhibitor S0859 (10µM). n = 4. Data are normalized to untreated ctrl. and shown as mean with S.E.M. error
bars and individual data points. *p < 0.05, ** p < 0.01, and **** p < 0.0001, respectively.
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FIGURE 6 | Roles of NHE1, NBCn1, and Merlin in TGFβ-induced invasiveness of Panc-1 cells. (A) Panc-1 cells were treated with siRNA against NHE1, NBCn1, and
/or Merlin as indicated, starved for 48 h, and treated or not with TGFβ-1 for 48 h, followed by Western blotting to assess protein expression levels. Data represent
three independent experiments. (B) Panc-1 cells were treated with siRNA against NHE1 or NBCn1 as indicated, treated or not with TGFβ-1 as above for 48 h, and
seeded at 50,000 cells/well in in serum-free medium in Matrigel-coated Boyden chambers. The lower chamber contained 10% FBS. Twenty-two hours later,
experiments were terminated and the number of invaded cells determined. (C) As (B), except including knockdown of merlin as indicated. n = 3–15 independent
experiments, each done in duplicate, per condition. *, **, ****) p < 0.05, 0.01, and 0.0001, respectively, 2-way ANOVA, ctrl. vs. TGFβ; #, ## p < 0.05, 0.01,
respectively, 2-way ANOVA between the indicated conditions.
relevance of TGFβ-mediated regulation of these transporters to
invasiveness in patients.
In conclusion, we show here that NHE1 and NBCn1
expression and NHE-dependent acid extrusion are upregulated
during TGFβ-1-induced EMT of Panc-1 cells. NHE1
upregulation is SMAD4-dependent, and SMAD4-deficient
BxPC-3 cells show no change in pHi regulation. The difference
between Panc-1 and BxPC-3 cells is corroborated in opposite
effects of TGFβ-1 on cell proliferation, which is increased
in Panc-1 and decreased in BxPC-3 cells by treatment with
this ligand. Knockdown of Merlin strongly potentiates
TGFβ-1-induced Panc-1 cell invasiveness in a manner
dependent on acid-extruding transporters. We suggest that
these transporters are novel players in the events induced during
TGFβ-1-induced EMT in PDAC cells.
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